2018 Cancer Center Business Summit Highlights

Complying with Pharmacy Standards: USP 797/USP 800

Gail Thompson

June 2018, Vol 8, No 6 - 2018 Cancer Center Business Summit Highlights

Oncology practices, hospitals, and pharmacies are struggling to understand wide variations in the application of sterile compounding and safe handling of oncology hazardous drugs, and the costs and operating burdens of compliance with and adherence to current pharmacy standards. At the 2018 combined meeting of the Association of Community Cancer Centers and the Cancer Center Business Summit, 3 cancer centers shared their stories and experiences related to pharmacy standards compliance. [ Read More ]

Using Cancer Drugs Wisely to Control Costs: Targeted Therapies May Hold the Key

Gail Thompson

May 2018, Vol 8, No 5 - 2018 Cancer Center Business Summit Highlights

How we use, label, study, and think about cancer drugs could make seismic changes in the pricing and access of cancer treatments for patients, but we need to rethink what we are doing first. Thought leaders from the provider, distribution, payer, and pharmaceutical arenas addressed these challenges at the 2018 combined meeting of the Association of Community Cancer Centers and the Cancer Center Business Summit. The meeting included a panel discussion about the costs of drugs, and the significant rise in the costs of cancer drugs after the US Food and Drug Administration (FDA) approval. [ Read More ]